Ligand validation:6ZFS

PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZFS_PX4_E_202	7%	38%	0.384	0.879	1.34	1.18	2	4	1	0	80%	0.8043
7R3V_PX4_E_202	14%	59%	0.305	0.888	0.62	0.92	-	2	4	0	80%	0.8043
6HAW_PX4_E_202	12%	34%	0.315	0.916	1.4	1.31	2	4	0	0	61%	0.6087
5KLV_PX4_J_101	8%	43%	0.337	0.818	1.27	0.97	3	4	0	0	100%	1
6XVF_PX4_E_202	6%	39%	0.416	0.882	1.29	1.18	2	5	1	0	80%	0.8043
6ZFT_PX4_E_202	5%	71%	0.47	0.923	0.42	0.68	-	1	0	0	80%	0.8043
8DJ0_PX4_A_1301	64%	83%	0.148	0.949	0.31	0.46	-	-	2	0	100%	1
8DJ1_PX4_A_1301	54%	89%	0.18	0.954	0.28	0.36	-	-	1	0	96%	0.9565
8DIV_PX4_A_1302	50%	71%	0.182	0.934	0.4	0.69	-	3	1	0	100%	1
8DIZ_PX4_A_1302	50%	81%	0.167	0.941	0.28	0.53	-	-	1	0	87%	0.8696
6P6X_PX4_A_2001	45%	71%	0.193	0.932	0.51	0.58	-	-	3	0	96%	0.9565

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.